During a meeting last week, the Food and Drug Administration’s Pharmacy Compounding Advisory Committee recommended that six previously restricted peptides be made available for pharmacy compounding.

Peptides are short chains of amino acids, the building blocks of proteins. Compounding is the preparation of customized medications for individual patients rather than the dispensing of conventionally manufactured, FDA-approved drugs.